List of Progenika Biopharma, S.A. patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8712696 Methods of prognosing a rheumatoid arthritis remission phenotype	Patent 8712696 was granted and assigned to Progenika Biopharma, S.A. on April, 2014 by the United States Patent and Trademark Office.		Progenika Biopharma, S.A.	United States Patent and Trademark Office	8712696	April 29, 2014
‌ US Patent 7914990 Methods and products for in vitro genotyping	Patent 7914990 was granted and assigned to Progenika Biopharma, S.A. on March, 2011 by the United States Patent and Trademark Office.		Progenika Biopharma, S.A.	United States Patent and Trademark Office	7914990	March 29, 2011
‌ US Patent 9637788 Discrimination of blood type variants	Patent 9637788 was granted and assigned to Progenika Biopharma, S.A. on May, 2017 by the United States Patent and Trademark Office.		Progenika Biopharma, S.A.	United States Patent and Trademark Office	9637788	May 2, 2017
‌ US Patent 10253366 Discrimination of blood type variants	Patent 10253366 was granted and assigned to Progenika Biopharma, S.A. on April, 2019 by the United States Patent and Trademark Office.		Progenika Biopharma, S.A.	United States Patent and Trademark Office	10253366	April 9, 2019
‌ US Patent 10830779 Lateral flow immunoassays for the detection of antibodies against biological drugs	Patent 10830779 was granted and assigned to Progenika Biopharma, S.A. on November, 2020 by the United States Patent and Trademark Office.	Progenika Biopharma, S.A.	Progenika Biopharma, S.A.	United States Patent and Trademark Office	10830779	November 10, 2020
‌ US Patent 9165108 Probes and methods for determining the presence or absence of genetic segments	Patent 9165108 was granted and assigned to Progenika Biopharma, S.A. on October, 2015 by the United States Patent and Trademark Office.		Progenika Biopharma, S.A.	United States Patent and Trademark Office	9165108	October 20, 2015
‌ US Patent 9109257 Prognostic method	Patent 9109257 was granted and assigned to Progenika Biopharma, S.A. on August, 2015 by the United States Patent and Trademark Office.		Progenika Biopharma, S.A.	United States Patent and Trademark Office	9109257	August 18, 2015